Publication scheme

NHS Kernow has followed guidance from the Information Commissioner and adopted its publication scheme for healthcare.
This scheme aims to provide you with information on the following:

Where possible, this information will be available on our website. However, some information may only be available as hard copy or other media.

You can also check if the information has been published in our disclosure log, which contains responses to all our FOI requests.

Rebate scheme

Prescribing rebates

NHS Kernow has a policy to agree and consider future rebates, and has arrangements for the drugs below.

Attention deficit hyperactivity disorder: Xaggitin

Company: Ethypharm
Product: Xaggitin
Type: Used to treat attention deficit hyperactivity disorder (ADHD)
Start date: 1 August 2017
End date: Rolling
Aligned to PrescQIPP: Yes

Anti-coagulant: Edoxaban

Company: Daiichi Sankyo
Product: Edoxaban
Type: Anti coagulant
Start date: 1 April 2018
End date: 31 December 2022
Aligned to PrescQIPP: Yes

Anti-psychotic medicine: Zaluron XL (Quetiapine XL)

Company: Fontus Health Limited
Product: Zaluron XL (Quetiapine XL)
Type: Anti-psychotic medicine
Start date: 1 August 2019
End date: 30 July 2024
Aligned to PrescQIPP: Yes

Atypical anti-psychotic medicine: Quetiapine Biquelle

Company: Aspire Pharma Limited
Product: Quetiapine – Biquelle
Type: Atypical anti-psychotic medicine
Start date: 1 April 2020
End date: 31 March 2021
Aligned to PrescQIPP: Yes

DVT: Rivaroxaban

Company: Bayer
Product: Rivaroxaban
Type: Prevent or treat a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs
Start date: 1 July 2020
End date: 1 December 2021
Aligned to PrescQIPP: Yes

Emollient for eczema: Balneum

Company: Almirall Limited
Product: Balneum
Type: Emollient for eczema
Start date: 23 June 2020
End date: 22 June 2022
Aligned to PrescQIPP: Yes

Inhaler: Clenil Modulite

Company: Chiesi Limited
Product: Clenil Modulite
Type: Inhaler
Start date: 1 August 2021
End date: 31 July 2023
Aligned to PrescQIPP: Yes

Inhaler: Fostair Nexthaler

Company: Chiesi Limited
Product: Fostair Nexthaler
Type: Inhaler
Start date: 1 May 2021
End date: 30 April 2023
Aligned to PrescQIPP: Yes

Inhaler: Fostair pMDI

Company: Chiesi Limited
Product: Fostair pMDI
Type: Inhaler
Start date: 1 August 2021
End date: 31 July 2023
Aligned to PrescQIPP: Yes

Inhaler: Sereflo

Company: CIPLA
Product: Sereflo
Type: Inhaler
Start date: 1 August 2021
End date: 31 July 2023
Aligned to PrescQIPP: Yes

Insulin: Aprida

Company: Aventis Pharma Limited trading as Sanofi
Product: Aprida
Type: Insulin
Start date: 1 April 2021
End date: 31 March 2022
Aligned to PrescQIPP: Yes

Insulin: Insuman

Company: Aventis Pharma Limited trading as Sanofi
Product: Insuman
Type: Insulin
Start date: 1 April 2021
End date: 31 March 2022
Aligned to PrescQIPP: Yes

Insulin: Lispro

Company: Aventis Pharma Limited trading as Sanofi
Product: Lispro
Type: Insulin
Start date: 1 April 2020
End date: 30 September 2021
Aligned to PrescQIPP: Yes

Pain relief patch: Fencino

Company: DS Ashbourne Limited (Part of the Ethypharm Group)
Product: Fencino
Type: Pain relief patch
Start date: 1 April 2016
End date: Rolling
Aligned to PrescQIPP: Yes

Parkinson's: Pipexus

Company: Ethypharm
Product: Pipexus
Type: For use in the treatment of Parkinson’s
Start date: 1 July 2018
End date: Rolling
Aligned to PrescQIPP: Yes

Prostate cancer: Firmagon® (degarelix)

Company: Ferring Pharmaceauticals
Product: Firmagon® (degarelix)
Type: Treatment for prostate cancer
Start date: 1 September 2019
End date: 31 August 2020
Aligned to PrescQIPP: Yes

Google Translate

Text Size

Change font

Contrast